# A Real World Study of Mobocertinib in Adults With Lung Cancer in China (MEANING)

> **NCT05863819** · — · WITHDRAWN · sponsor: **Takeda**

## Conditions studied

- Non-small Cell Lung Cancer (NSCLC)

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT05863819
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-03-30
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-02-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Business reason, unrelated to product safety
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05863819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05863819, "A Real World Study of Mobocertinib in Adults With Lung Cancer in China (MEANING)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05863819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*